Tennessee Keytruda Lawyer
Keytruda, the trade name for the drug pembrolizumab, is a medication approved by the U.S. Food and Drug Administration (FDA) for use in patients with various forms of cancer, including melanoma, Hodgkin lymphoma, and lung cancer. But despite its recent popularity, the FDA has also warned against the use of Keytruda for other types of cancers, notably multiple myeloma, and the drug is not currently approved for use in those patients after the agency received adverse reports during clinical trials.
Indeed, there is mounting evidence Keytruda may be unsafe for patients with other types of cancer as well, including metastatic urothelial cancer. If you or a loved one have taken Keytruda and suffered any serious side effects as a result, you may be entitled to compensation from the drug’s manufacturers and other negligent parties. The qualified Tennessee Keytruda lawyers at Fox & Farley can review your case and help you decide whether to take legal action.
FDA Warns of Keytruda Risks to Multiple Myeloma, Urothelial Cancer Patients
In July 2017, the FDA halted two clinical trials evaluating the use of Keytruda in patients with multiple myeloma, which is a cancer affecting the body’s plasma cells. The FDA said the “interim results from both trials demonstrated an increased risk of death for patients” taking Keytruda in combination with two other drugs, dexamethasone and an “immunomodulatory agent.” The FDA emphasized that Keytruda is not approved for the treatment of multiple myeloma, although it may still be prescribed for other types of cancer as noted above.
But in May 2018, the FDA issued a new alert warning that there was a risk of “decreased survival associated with the use of Keytruda” as a single therapy to treat metastatic urothelial cancer (i.e., cancer of the urinary system). Once again, the FDA cited data from two clinical trials. Keytruda is currently “under accelerated approval” for use in metastatic urothelial cancer patients, and while the FDA has not halted the trials as it did in the multiple myeloma cases, it has cautioned doctors and patients to “report adverse events or side effects” to the FDA.
Suffering from Keytruda-related Side Effects? Call Fox & Farley, Attorneys at Law, Today
All drugs carry certain risks. But cancer medications in the clinical trial stage are especially risky. And these are not small risks. Many Keytruda patients have experienced lung and liver problems, as well as kidney failure. So if you have been taking Keytruda, either as part of a trial or as an approved drug for your particular form of cancer, you need to report any of these potentially deadly side effects. You should also contact a qualified Tennessee Keytruda lawyer to explore your legal options.
Fox & Farley serves clients in Tennessee cities such as Knoxville, Clinton, Oak Ridge, Kingston, La Follette, Maryville, Sevierville, Pigeon Forge, Gatlinburg and others throughout Knox County, Anderson County, Roane County, Macon County, Blount County, Campbell County, Claiborne County, Morgan County, Scott County, Sevier County and Union County. Call us today at 866-862-4855 to schedule a free, no-obligation consultation today.